Cardiol Therapeutics (CRDL) Other Non Operating Income (2020 - 2026)

Cardiol Therapeutics has reported Other Non Operating Income for 7 years, with the latest figure at $158237.6 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 312.48% year-over-year to $158237.6; the trailing twelve-month figure through Mar 2026 stood at $914266.7 (up 358.04% YoY), and the FY2025 full-year result was $682481.9, up 300.29% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $158237.6, down from $1.3 million in the prior quarter.
• The five-year high for Other Non Operating Income was $2.3 million in Q3 2022, with the low at -$1.1 million in Q1 2022.
• Historically, Other Non Operating Income has averaged $193653.9 across 5 years, with a median of $67986.2 in 2025.
• The largest YoY upside for Other Non Operating Income was 2201.1% in 2022 against a maximum downside of 2657.74% in 2022.
• Cardiol Therapeutics' Other Non Operating Income stood at -$389210.5 in 2022, then jumped by 150.26% to $195602.4 in 2023, then slumped by 246.66% to -$286871.5 in 2024, then soared by 555.92% to $1.3 million in 2025, then plunged by 87.9% to $158237.6 in 2026.
• The last three Other Non Operating Income figures came in at $158237.6 (Q1 2026), $1.3 million (Q4 2025), and $67986.2 (Q3 2025), per Business Quant data.